RA
SMED

Royce & Associates’s Sharps Compliance Corp SMED Stock Holding History

Royce & Associates’s Portfolio SMED Stock Details SMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-851,378
Closed -$2.49M – 994
2022
Q2 		$2.49M Sell
851,378
-198,994
-19% -$831K 0.03% 637
2022
Q1 		$6.2M Sell
1,050,372
-147,200
-12% -$925K 0.05% 498
2021
Q4 		$8.54M Buy
1,197,572
+52,579
+5% +$404K 0.06% 435
2021
Q3 		$9.47M Buy
1,144,993
+204,793
+22% +$1.9M 0.07% 428
2021
Q2 		$9.68M Buy
940,200
+53,500
+6% +$745K 0.07% 439
2021
Q1 		$12.7M Buy
886,700
+231,600
+35% +$2.98M 0.09% 379
2020
Q4 		$6.19M Sell
655,100
-81,000
-11% -$619K 0.05% 506
2020
Q3 		$4.62M Buy
736,100
+138,200
+23% +$1.01M 0.05% 493
2020
Q2 		$4.2M Buy
597,900
+466,400
+355% +$3.32M 0.05% 493
2020
Q1 		$1.04M Buy
+131,500
New +$678K 0.01% 727

Royce & Associates's SMED Position: Q3 2022 in Review

Royce & Associates sold out of Sharps Compliance Corp (SMED) in Q3 2022, closing a stake of 851,378 shares — an estimated $2.49M sold.

Royce & Associates first reported a position in SMED in Q1 2020 and held it in 10 quarters. The position peaked at $12.7M in Q1 2021. 0 funds tracked by Wall St. Rank hold SMED as of Q3 2022.

  • Royce & Associates reported no remaining Sharps Compliance Corp position as of Q3 2022 after selling out during the quarter.
  • Royce & Associates sold 851,378 Sharps Compliance Corp shares in Q3 2022, an estimated $2.49M.
  • Royce & Associates first reported a position in Sharps Compliance Corp in Q1 2020 and held it in 10 quarters.
  • Royce & Associates's Sharps Compliance Corp position peaked at $12.7M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q3 2022.

Based on Royce & Associates's 13F filing for Q3 2022, filed 3 Nov 2022.